Evidence map›Paper›PMID 30450362›Full record

ArticleNeurophotonics2018

Challenges and opportunities in neurophotonics discussed at the International Conference on Biophotonics 2017.

Mark R Hutchinson, Paul R Stoddart, Anita Mahadevan-Jansen

Open access · hybridAbstract readNews
In one paragraph

Article in Neurophotonics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Mark R HutchinsonUniversity of Adelaide, ARC Centre of Excellence for Nanoscale Biophotonics (CNBP), Adelaide, Australia.ORCID https://orcid.org/0000-0003-2154-5950
Paul R StoddartSwinburne University of Technology, ARC Training Center in Biodevices, Melbourne, Australia.ORCID https://orcid.org/0000-0003-4882-9400
Anita Mahadevan-JansenVanderbilt University, Biophotonics Center and Department of Biomedical Engineering, Nashville, Tennessee, United States.
Swinburne University of Technology · AUThe University of Adelaide · AUVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurophotonics is an exploding field that spans the intersection of light and neurons for fundamental discovery and clinical translation. Optical technologies have significantly impacted brain research by probing into the mysteries of the brain, modulating brain activity, and improving patient care. Based on a discussion held at the International Conference on Biophotonics 2017, a group of leading researchers brainstormed to identify areas of unmet need in neuroscience and medicine, where biophotonics research could have the highest affect. We present two areas of future growth that spans basic research and clinical needs: management of chronic pain and interventional neuroimmunology. There are many directions within these areas that could be pursued for the ultimate goal of improved understanding of the brain and enhanced care of patients with neurological disorders.

Indexed as

neurological disordersneurophotonicspain

Identifiers

PMID30450362
PMCPMC6225684
OpenAlexW2963148301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.